Insider Activity · SEC Form 4
Anteris Technologies Global Corp. (AVR) Insider Trading
Anteris Technologies is an Australian-listed cardiovascular device company developing the DurAVR transcatheter aortic valve — a single-piece bovine pericardium TAVR designed to replicate native valve hemodynamics. Clinical-stage with ongoing US pivotal trial; TAVR market entry is the defining milest
Buys: 0 · —
Sales: 2 · $9.43M
Recent insider transactions
| Insider | Type | Shares | Price | Value | Date | Source |
|---|---|---|---|---|---|---|
| L1 Capital Pty Ltd10% Owner | SELL | 714,138 | $8.17 | $5.83M | Jul 30, 2026 | Form 4 → |
| L1 Capital Pty Ltd10% Owner | SELL | 441,548 | $8.14 | $3.60M | Jul 28, 2026 | Form 4 → |